重组Anti-Melanoma抗体[HMB45 + M2-7C10 + M2-9E3]
Anti-Melanoma antibody [HMB45 + M2-7C10 + M2-9E3]
- Recombinant
- 了解详情
4
(2 Reviews)
|
(37 Publications)
Mouse Recombinant Multiclonal Melanoma antibody. Suitable for Flow Cyt, IHC-P, IHC-Fr and reacts with Human samples. Cited in 37 publications.
查看别名
Antigen LB39-AA, Antigen SK29-AA, MART-1, Melan A, Melan A protein, Melanoma antigen recognized by T-cells 1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Melanoma antibody [HMB45 + M2-7C10 + M2-9E3] (AB732)
ab732 staining Melanoma in Human lymph node tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
反应性数据
产品详情
This cocktail is HMB45 + two different clones of MART-1[M2-7C10] + [M2-9E3]. HMB34 isotype: IgG1/kappa and both clones of MART-1: IgG2b + IgG2b
HMB-45 and MART-1 are coexpressed in the majority of melanomas, as well as uniquely expressed in certain cases. Thus, the HMB-45 and MART-1 cocktail is potentially more sensitive than HMB-45 or MART-1 alone. MART-1 is a cocktail of clones M2-7C10 and M2-9E3. The combination of HMB-45 and the MART-1 cocktail make this triple antibody cocktail a first-order pan melanoma screener.
This product was changed from ascites to tissue culture supernatant on 14/07/17. The following lots are from ascites and are still in stock as of 14/07/17 – GR313023 and GR3175007. Lot numbers higher than GR313023 will be from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly.
What is an oligoclonal antibody?
This oligoclonal antibody is a cocktail of monoclonal antibodies that have been carefully selected. Oligoclonal antibodies have not only the specificity and batch-to-batch consistency of a monoclonal antibody, but also have the advantage of the sensitivity of a polyclonal antibody due to their ability to recognize multiple epitopes on an antigen.
性能和储存信息
形式
纯度
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
文献 (37)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 14:24843 PubMed39438602
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer discovery 15:179-201 PubMed39354883
2024
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:3553-3586 PubMed38719996
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37958830
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 120:e2214350120 PubMed36634146
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell 185:2071-2085.e12 PubMed35561684
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 28:752-765 PubMed35411077
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34439274
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed33924486
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 40:1792-1805 PubMed33564068
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com